Skip to main content
. 2015 Oct 5;6(38):41350–41359. doi: 10.18632/oncotarget.5534

Figure 1. Effects of CD4+ CD25+ proportion of T cells on survival with 95%CI among BC patients, a. progression-free survival, b. overall survival.

Figure 1